ENCBS047AWE / cell line
Summary
- Status
- released
- Term name
- HCT116
- Term ID
- EFO:0002824
- Summary
- Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens BRD4 treated with 1 μM 5-Phenyl-1H-indole-3-acetic acid for 6 hours
- Starting amount
- 75000cells
- Separated from biosample
- ENCBS228RKP
Attribution
ENCODE4 project
- Lab
- Erez Aiden, Baylor
- Award PI
- Erez Aiden, Baylor
- Submitted by
- Bonita Lam
- Source
- Dr. Masato Kanemaki
- Project
- ENCODE
- External resources
- Aliases
- michael-snyder:HCT116-BRD4-clone1-treated-new_1
Treatment details
- Treatment
- 1 μM 5-Phenyl-1H-indole-3-acetic acid for 6 hours
- Type
- chemical
- Purpose
- perturbation
Genetic modifications
Accession | Category | Purpose | Method | Nucleic acid delivery method | Site |
---|---|---|---|---|---|
ENCGM628AIR | insertion | expression | CRISPR | ||
ENCGM126ANC | insertion | tagging | CRISPR |
|
Donor information
- Status
- released
- Accession
- ENCDO000ABE
- Aliases
- encode:donor of HCT-116, bradley-bernstein:Donor of HCT-116 cells
- Species
- Homo sapiens
- Life stage
- adult
- Age
- 48 years
- Sex
- male
- Health status
- colorectal carcinoma
- External resources
- References